Company / Current Assets
LENZ Therapeutics, Inc. Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$301.4M
FY2025
5-year range
$67.2M / $381.7M
FY2021-FY2025
Trend
+42.2%
vs FY2024
Sector context
#164 of 213
Health Care
What the data says
LENZ Therapeutics, Inc.'s current assets of $301M is lower than 77% of companies in the Health Care sector (FY2025). Improved from $67M to $301M over the past 2 years.
Based on SEC 10-K filings.
$301M in FY2025 with a 5-year CAGR of +70.2%.
Improved from $67M to $301M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +70.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 213This company $301.4M Sector average $2.5B
▼
-88.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +70.2%, indicating consistent growth.
- In FY2025, current assets increased 42.2% year-over-year.
- Ranks #164 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $301.4M | +42.2% |
| FY2024 | $211.9M | +215.1% |
| FY2023 | $67.2M | -75.6% |
| FY2022 | $275.4M | -27.9% |
| FY2021 | $381.7M | +1708.9% |
| FY2020 | $21.1M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026